GRAS Ingredients for Use in Medical Foods: An Overview of FDA Regulation

May 26, 2016

The medical foods market is growing! Download this 21-page article to learn how to navigate the regulatory "gray zone" for these products as overseen by the FDA, and how Generally Recognized as Safe filings come into play.

Read More

Journal Article: General and Genetic Toxicology of Guayusa Concentrate (Ilex guayusa)

January 29, 2016

View the latest scientific paper published in the International Journal of Toxicology by Robert McQuate, Ph.D. and Richard Kraska, Ph.D. of GRAS Associates.

Read More

Medical Foods: An Evidence-Based Approach to Product Development

November 11, 2015

Learn about the business and market expansion opportunities for food ingredients in the medical food category

Read More

5 things you need to know about GRAS filings

July 8, 2015

Learn five important facts about GRAS filings you should be aware of when considering this regulatory route for your food ingredient

Read More

The Future of GRAS Regulations

June 9, 2015

In this recent expert opinion article published in Nutritional Outlook, Dr. McQuate and Dr. Kraska weigh in on how the GRAS regulations came to be and how they are expected to evolve in years to come.

Read More


June 3, 2013

What is the difference between Generally Recognized as Safe (GRAS) and New Dietary Ingredient (NDI) filings, and how can the choice affect your business?

Read More

Health, safety and regulatory advances for stevia-derived sweeteners

July 1, 2011

Read More

Ensuring the Safety of Sweeteners from Stevia

April 1, 2011

Successful documentation of the safety of high-purity stevia-derived sweeteners has paved the way for acceptance and regulatory authorizations by FDA and several international bodies. By Dr. Robert McQuate, Ph.D.

Read More